28-02-2023, 07:27

Alvotech Announces Webcast of 2022 Full Year Financial

Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar
Globe Newswire28-02-2023, 07:27
6-02-2023, 16:08

Alvotech enters into commercialization agreement with

Advanz Pharma will commercialize AVT23, a proposed biosimilar to Xolair® (omalizumab) in the European Economic Area,
Globe Newswire6-02-2023, 16:08
2-02-2023, 20:05

Surface Oncology to Participate in the 2023 Guggenheim

CAMBRIDGE, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a clinical-stage immuno-oncology
Globe Newswire2-02-2023, 20:05
2-02-2023, 02:42

Premiere Synthetic Biology Event on Track for Record

SynBioBeta Global Synthetic Biology Conference Registration Open SynBioBeta announces event dates, keynotes, sponsors,
Globe Newswire2-02-2023, 02:42
31-01-2023, 21:19

Envision Pharma Group Hires Leading Industry Executives

PHILADELPHIA, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Envision Pharma Group (Envision) today announced the appointment of
Globe Newswire31-01-2023, 21:19